Ibrutinib-Induced Uveitis: A Case of Rapid Ocular Toxicity in Mantle Cell Lymphoma

被引：0
|
作者：
Ramachandran, Sai Prasad [1 ]
Rayapureddi, Karthik [1 ]
Kriplani, Kushal [2 ]
Khurana, Harshit [1 ]
机构：
[1] Armed Forces Med Coll, Pune, Maharashtra, India
[2] Vardhaman Mahavir Med Coll & Safdurjung Hosp, Delhi, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MCL; ibrutinib; uveitis; mantle cell lymphoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MCL-640
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [41] Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
    Tam, Constantine S.
    Anderson, Mary Ann
    Pott, Christiane
    Agarwal, Rishu
    Handunnetti, Sasanka
    Hicks, Rodney J.
    Burbury, Kate
    Turner, Gillian
    Di Iulio, Juliana
    Bressel, Mathias
    Westerman, David
    Lade, Stephen
    Dreyling, Martin
    Dawson, Sarah-Jane
    Dawson, Mark A.
    Seymour, John F.
    Roberts, Andrew W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1211 - 1223
  • [42] Mantle cell lymphoma in the ocular adnexal region
    Looi, A
    Gascoyne, RD
    Chhanabhai, M
    Connors, JM
    Rootman, J
    White, VA
    OPHTHALMOLOGY, 2005, 112 (01) : 114 - 119
  • [43] Choroidal and Ocular Adnexal Lymphoma Extension From Systemic Mantle Cell Lymphoma: A Case Report
    Bou Ghanem, Ghazi O.
    Daye, Ghassan N.
    Saade, Marie Christelle W.
    Farhat, Jad H.
    Bejjani, Noha A.
    Saade, Michel J.
    Farhat, Hussein Z.
    Ghazi, Nicola G.
    HEMASPHERE, 2021, 5 (08): : E599
  • [44] Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report
    Kaur, Varinder
    Swami, Arjun
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (03) : 235 - 239
  • [45] Ibrutinib as bridge therapy to allogeneic stem cell transplantation in refractory mantle cell lymphoma (MCL): A case report
    Grillo, G.
    Zucchetti, E.
    Zilioli, V. R.
    Rusconi, C.
    Forno, B.
    Zancanella, M.
    Meli, E.
    Minga, P.
    Cairoli, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S169 - S169
  • [46] Mantle cell lymphoma: poor prognosis of patients progressing under ibrutinib
    Machet, Antoine
    Cayssials, Emilie
    Leleu, Xavier
    Guidez, Stephanie
    HEMATOLOGIE, 2016, 22 (04): : 252 - +
  • [47] Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly
    Ruella, Marco
    Soubeyran, Pierre
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 432 - 436
  • [48] Ibrutinib-a new standard treatment for relapsed mantle cell lymphoma?
    Martin, Peter
    LANCET, 2016, 387 (10020): : 728 - 729
  • [49] Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects
    Hershkovitz-Rokah, Oshrat
    Pulver, Dana
    Lenz, Georg
    Shpilberg, Ofer
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 306 - 319
  • [50] Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma
    Liu, Yang
    Bell, Taylor
    Zhang, Hui
    Sun, Yuting
    Li, Carrie J.
    Feng, Ningping
    Huang, Shengjian
    Guo, Hui
    Wang, Jack
    Ahmed, Makhdum
    Zhang, Victoria
    Lam, Laura T.
    Nomie, Krystle
    Zhang, Liang
    Di Francesco, Maria E.
    Marszalek, Joe
    Wang, Michael
    BLOOD, 2016, 128 (22)
12345